PPCB
NASDAQ
$1.38
Propanc Biopharma Inc (PPCB)
Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. The company is headquartered in Camberwell, Australia.
Sector:
Healthcare
Industry:
Biotechnology
Target: $1.52 (+10.14%)
Market Cap
$2.50M
P/B Ratio
0.18
FCF 5Y CAGR
+22.04%
Price Chart
Valuation
Market Cap$2.50M
P/B0.18
Profitability
EBITDA-$12M
EPS-$0.50
Financial Health
Debt-to-Equity1.1%
Growth & Risk
FCF 5Y CAGR+22.04%
Sharpe Ratio-1.03